Literature DB >> 3502667

Healing of rachitic lesions in chicks by 24R,25-dihydroxycholecalciferol administered locally into bone.

C Lidor1, I Atkin, A Ornoy, S Dekel, S Edelstein.   

Abstract

In an attempt to further define the nature of the active metabolite in bone formation, a series of experiments were conducted whereby vitamin D metabolites were administered locally in vivo into the proximal epiphyseal growth plate of the tibiae of rachitic chicks. Local administration of 3 micrograms of 24,25(OH)2D3 in vivo to D-deficient chicks resulted in disappearance of the rachitic lesions in the same leg. Administration of 1 microgram 1,25(OH)2D3 in a similar manner failed to show any sign of healing. Injection of 5 micrograms 25(OH)D3 was followed by recovery from rickets in both the injected right leg and in the vehicle-injected left tibia, although the recovery was more pronounced in the injected leg. Lower doses of 0.3 or 1 microgram 24,25(OH)2D3 failed to reverse the rachitic lesions and induced only minimal recovery. These findings suggest that 24,25(OH)2D3 at the higher doses has a direct local effect on cartilage and bone, while 1,25(OH)2D3 has no such effect in chicks. 25(OH)D3 is probably absorbed from the epiphyses into the blood stream and converted into the active metabolites, which were indeed detected in the blood to exert its systemic effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502667     DOI: 10.1002/jbmr.5650020203

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  A model for investigating the local action of bone-acting agents in vivo: effects of hPTH(1-34) on the secondary spongiosa in the rat.

Authors:  T Takano-Yamamoto; G A Rodan
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

2.  Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.

Authors:  H Jüppner; P F Hoyer; K Latta; L Winkler; G Offner; J Brodehl
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

3.  Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.

Authors:  R G Erben; H Weiser; F Sinowatz; W A Rambeck; H Zucker
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

4.  Preferential accumulation in vivo of 24R,25-dihydroxyvitamin D(3) in growth plate cartilage of rats.

Authors:  E G Seo; Z Schwartz; D D Dean; A W Norman; B D Boyan
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

5.  Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.

Authors:  B Mortensen; J O Gordeladze; L Aksnes; K M Gautvik
Journal:  Calcif Tissue Int       Date:  1990-05       Impact factor: 4.333

6.  Serum vitamin D metabolites in cadmium-exposed persons with renal damage.

Authors:  K Nogawa; I Tsuritani; T Kido; R Honda; M Ishizaki; Y Yamada
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

7.  Effect of modulating dietary vitamin D on the general bone health of rats during posterolateral spinal fusion.

Authors:  Neil Bhamb; Linda Kanim; Ruben Maldonado; Mark Svet; Melodie Metzger
Journal:  J Orthop Res       Date:  2018-01-16       Impact factor: 3.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.